-+ 0.00%
-+ 0.00%
-+ 0.00%

SUMITOMO PHARMA CO LTD: SUMITOMO PHARMA AMERICA ANNOUNCES FIRST PATIENT RECEIVES TREATMENT IN PHASE 1/2A STUDY FOR INVESTIGATIONAL THERAPY DSP-3077 FOR RETINITIS PIGMENTOSA

Reuters·08/13/2026 00:15:44

Please log in to view news